Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022

Front Immunol. 2023 May 10:14:1135334. doi: 10.3389/fimmu.2023.1135334. eCollection 2023.

Abstract

Background: Since the coronavirus disease 2019 (COVID-19) has spread throughout the world, many studies on innate immunity in COVID-19 have been published, and great progress has been achieved, while bibliometric analysis on hotspots and research trends in this field remains lacking.

Methods: On 17 November 2022, articles and reviews on innate immunity in COVID-19 were recruited from the Web of Science Core Collection (WoSCC) database after papers irrelevant to COVID-19 were further excluded. The number of annual publications and the average citations per paper were analyzed by Microsoft Excel. Bibliometric analysis and visualization of the most prolific contributors and hotspots in the field were performed by VOSviewer and CiteSpace software.

Results: There were 1,280 publications that met the search strategy on innate immunity in COVID-19 and were published from 1 January 2020 to 31 October 2022. Nine hundred thirteen articles and reviews were included in the final analysis. The USA had the highest number of publications (Np) at 276 and number of citations without self-citations (Nc) at 7,085, as well as an H-index of 42, which contributed 30.23% of the total publications, followed by China (Np: 135, Nc: 4,798, and H-index: 23) with 14.79% contribution. Regarding Np for authors, Netea, Mihai G. (Np: 7) from the Netherlands was the most productive author, followed by Joosten, Leo A. B. (Np: 6) and Lu, Kuo-Cheng (Np: 6). The Udice French Research Universities had the most publications (Np: 31, Nc: 2,071, H-index: 13), with an average citation number (ACN) at 67. The journal Frontiers in Immunology possessed the most publications (Np: 89, Nc: 1,097, ACN: 12.52). "Evasion" (strength 1.76, 2021-2022), "neutralizing antibody" (strength 1.76, 2021-2022), "messenger RNA" (strength 1.76, 2021-2022), "mitochondrial DNA" (strength 1.51, 2021-2022), "respiratory infection" (strength 1.51, 2021-2022), and "toll-like receptors" (strength 1.51, 2021-2022) were the emerging keywords in this field.

Conclusion: The study on innate immunity in COVID-19 is a hot topic. The USA was the most productive and influential country in this field, followed by China. The journal with the most publications was Frontiers in Immunology. "Messenger RNA," "mitochondrial DNA," and "toll-like receptors" are the current hotspots and potential targets in future research.

Keywords: COVID-19; CiteSpace; VOS viewer; WoSCC; bibliometric analysis; innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bibliometrics
  • COVID-19*
  • DNA, Mitochondrial
  • Humans
  • Immunity, Innate
  • RNA, Messenger

Substances

  • DNA, Mitochondrial
  • RNA, Messenger

Grants and funding

This work was supported by the Science and Technology Research Project of the Education Department of Jiangxi Province (No. 170865) (PL), the Gannan Medical University Project (No. YB201803) (PL), The National Public Fund for Study Abroad and CSC Scholarship (Grant No. 202008360179) (PL), and the Natural Science Foundation of Jiangxi Province (No. 20202BABL206012) (Y-LL).